Researchers simulated interactions between microbial molecules and neural receptors to explore whether gut bacteria might influence brain chemistry. To study possible interactions between receptors ...

A review published in Genomic Psychiatry by Dr. Peng Lei and colleagues presents a sweeping synthesis of tau protein research ...

Newborn babies and patients with Alzheimer's disease share an unexpected biological trait: elevated levels of a well-known biomarker for Alzheimer's. This is shown in a study led by researchers at the ...

Alzheimer’s disease and other neurodegenerative disorders cause abnormal tau protein aggregation. Until recently, researchers have mostly focused on the phosphorylated form of tau for diagnosing and ...

New research shows that much more work needs to be done before a simple blood test to diagnose Alzheimer’s disease, perhaps even years before symptoms appear, will be available. The study “Performance ...

Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from ...

For over a century, Alzheimer's disease (AD) has been considered irreversible. Consequently, research has focused on disease ...

Researchers have discovered a biomarker for Alzheimer's disease in the cerebrospinal fluid known as MTBR-tau243 can be used to track the progression of the disease and could speed drug development.

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — In this Healio Video Perspective, Suzanne E. Schindler, MD, PhD, revealed phosphorylated tau ...

Please provide your email address to receive an email when new articles are posted on . The Klotho protein, but not the KL-VS haplotype, varies depending on clinical stage of Alzheimer's disease and ...